156 related articles for article (PubMed ID: 35241535)
1. Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement.
Nieder C; Dalhaug A; Mannsåker B
In Vivo; 2022; 36(2):801-805. PubMed ID: 35241535
[TBL] [Abstract][Full Text] [Related]
2. LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy.
Nieder C; Yobuta R; Mannsåker B
Cureus; 2020 Apr; 12(4):e7633. PubMed ID: 32399365
[TBL] [Abstract][Full Text] [Related]
3. External Validation of the LabBM Score in Patients With Brain Metastases.
Nieder C; Dalhaug A; Pawinski A
J Clin Med Res; 2019 May; 11(5):321-325. PubMed ID: 31019625
[TBL] [Abstract][Full Text] [Related]
4. Neurological Death After Radiotherapy for Brain Metastases: Role of the LabBM Score.
Nieder C; MannsÅker B; Yobuta R
Anticancer Res; 2021 Jan; 41(1):341-345. PubMed ID: 33419829
[TBL] [Abstract][Full Text] [Related]
5. Palliative Radiotherapy for Non-metastatic Non-small-cell Lung Cancer: Impact of Blood Test Results on Survival.
Nieder C; Imingen KS
In Vivo; 2023; 37(2):771-776. PubMed ID: 36881095
[TBL] [Abstract][Full Text] [Related]
6. Serum Lactate Dehydrogenase Contributes to Prognostic Assessment in Patients With Oligometastatic Cancer and Brain Involvement.
Nieder C; Dalhaug A; Pawinski A
In Vivo; 2019; 33(1):229-232. PubMed ID: 30587628
[TBL] [Abstract][Full Text] [Related]
7. Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score.
Berghoff AS; Wolpert F; Holland-Letz T; Koller R; Widhalm G; Gatterbauer B; Dieckmann K; Birner P; Bartsch R; Zielinski CC; Weller M; Preusser M
Neuro Oncol; 2017 Sep; 19(9):1255-1262. PubMed ID: 28096493
[TBL] [Abstract][Full Text] [Related]
8. Expansion of the LabBM Score: Is the LabPS the Best Tool Predicting Survival in Patients With Brain Metastases?
Nieder C; Yobuta R; Mannsåker B
Am J Clin Oncol; 2021 Feb; 44(2):53-57. PubMed ID: 33350680
[TBL] [Abstract][Full Text] [Related]
9. The LabBM score is an excellent survival prediction tool in patients undergoing palliative radiotherapy.
Nieder C; Dalhaug A; Haukland E
Rep Pract Oncol Radiother; 2021; 26(5):740-746. PubMed ID: 34760308
[TBL] [Abstract][Full Text] [Related]
10. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
[TBL] [Abstract][Full Text] [Related]
11. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Blood Test Results Predicting Prognosis in Patients Undergoing Whole-brain Radiotherapy for Brain Metastases.
Nieder C; Stanisavljevic L; Månnsaker B
Anticancer Res; 2024 Jun; 44(6):2637-2643. PubMed ID: 38821600
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer.
Kissel M; Martel-Lafay I; Lequesne J; Faivre JC; Le Péchoux C; Stefan D; Barraux V; Loiseau C; Grellard JM; Danhier S; Lerouge D; Chouaid C; Gervais R; Thariat J
BMC Cancer; 2019 Dec; 19(1):1237. PubMed ID: 31856742
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
16. Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
Juan O; Popat S
Clin Lung Cancer; 2017 Nov; 18(6):595-606. PubMed ID: 28377206
[TBL] [Abstract][Full Text] [Related]
17. Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.
Buglione M; Jereczek-Fossa BA; Bonù ML; Franceschini D; Fodor A; Zanetti IB; Gerardi MA; Borghetti P; Tomasini D; Di Muzio NG; Oneta O; Scorsetti M; Franzese C; Romanelli P; Catalano G; Dell'Oca I; Beltramo G; Ivaldi GB; Laudati A; Magrini SM; Antognoni P;
Lung Cancer; 2020 Mar; 141():1-8. PubMed ID: 31926440
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
19. Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement.
Nieder C; Marienhagen K; Dalhaug A; Aandahl G; Haukland E; Pawinski A
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):447-52. PubMed ID: 24702741
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.
Lagerwaard FJ; Levendag PC; Nowak PJ; Eijkenboom WM; Hanssens PE; Schmitz PI
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):795-803. PubMed ID: 10098435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
